2 reports

  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • PIPELINE BY FLEX PHARMA INC, H1 2018

It was also under development for cancer pain, chronic inflammatory and diabetic neuropathy.

  • Pathology
  • Research And Development
  • Therapy
  • United States
  • Flex Pharma, Inc.
  • Apr 14, 2015: Hydra Biosciences Receives Approval from Health Canada to Begin Phase 1 Trial for HX-100

BRIGHAM AND WOMEN' S HOSPITAL IS INVESTIGATING SMALL MOLECULES TO INHIBIT TRPA## AND TRPV## FOR THE TREATMENT OF PAIN SUCH AS INFLAMMATORY PAIN, NEUROPATHIC AND CHRONIC PAIN.

  • Pathology
  • Pharmaceutical
  • United States
  • Product Initiative
  • Flex Pharma, Inc.